Michael Rendl, MD
- PROFESSOR | Cell, Developmental & Regenerative Biology
- PROFESSOR | Dermatology
Research Topics:Developmental Biology, Morphogenesis, Regeneration, Stem Cells
Michael Rendl is a stem cell biologist studying the function of stem cell niches. A major focus of his work is to uncover how specialized Dermal Papilla cells act as instructive niche for hair follicle stem cells during embryonic hair follicle formation and adult hair growth and regeneration.
For more detailed information, please visit the Rendl Lab website.
Multi-Disciplinary Training AreaDevelopment Regeneration and Stem Cells [DRS]
MD, Medical University of Vienna
Postdoctoral Fellowship, Rockefeller University
Irma T. Hirschl Trust Research Award
Research Career Development Award Dermatology Foundation
Schrodinger Fellow of the Austrian Science Fund
Max Kade Fellow of the Austrian Academy of Sciences
AESCA Award for Dermatological Research
The Rendl Laboratory studies the formation and function of stem cell niches. Specifically, we utilize genetic mouse models for embryonic hair follicle formation and for adult hair growth and regeneration to uncover how specialized Dermal Papilla (DP) cells act as instructive niche cells for hair follicle stem cells. A major focus is also to define how DP cells acquire the hair-inducing cell fate in the first place that sets them apart from regular skin fibroblasts. Insights from these studies will reveal general mechanisms on how stem cell niches function and provide a platform for developing hair regenerative therapies. For more detailed information, please visit the Rendl Lab website.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Rendl did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.